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Ahmed Yosry ba Department of Pediatrics, Zagazig University, Zagazig
b Department of Cardiology, Zagazig University, Zagazig
a,b EgyptBackground: Childhood obesity is a major risk factor for cardiovascular diseases in children and adults.
Objectives: The purpose of this study was to evaluate the serum leptin level and the cardiac changes in normoten-
sive obese children and to study the relationship between left ventricular mass index (LVMI) and serum leptin with
the parameters of metabolic syndrome (MS) in obese children.
Methods: This study was conducted in al Jeddani Hospital and Ibn Sina College Hospital in Saudi Arabia in the
period from July 2012 to December 2013, and included 82 obese children. Their mean age was 10.2 ± 2.8 years; they
were divided into 25 obese children with MS and 57 obese children without MS, and 40 healthy age- and
sex-matched children were also included in the study as a control group. All children were subjected to clinical
assessment including standing height, body weight, body mass index (BMI), waist circumference (WC), and blood
pressure measurements. All children received an echocardiographic examination (2-dimensional, M-mode, Doppler,
and tissue Doppler echocardiograpy) and laboratory assessment of serum leptin level, fasting glucose, fasting
insulin, the homeostatic model assessment for insulin resistance (HOMA) index, total cholesterol, triglycerides,
and high- and low-density lipoprotein profile.
Results: BMI, BMI standard deviation score, WC, fasting glucose, fasting insulin, HOMA index and the serum
leptin level were significantly higher in obese children compared to control group (p < 0.05). The LVMI were
increased in the obese compared to the control group (p < 0.001) while left ventricle systolic and diastolic functions
did not differ in obese versus control group (p > 0.05). There was a significant positive correlation between both
LVMI and serum leptin level in comparison to BMI, WC, fasting glucose, fasting insulin, HOMA, triglycerides,
and low-density lipoprotein in all obese children, especially the MS group. However, there was a significant
negative correlation between both LVMI and serum leptin level in comparison to high-density lipoprotein.
Conclusion: Assessment of LVMI as routine echocardiographic examinations and serum leptin level might be a
feasible and reliable method for the evaluation of obesity and its related cardiovascular risks during childhood that
can predict metabolic syndrome and insulin resistance.
 2015 Production and hosting by Elsevier B.V. on behalf of King Saud University. This is an open access article
under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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Abbreviations
LVMI left ventricular mass index
BMI body mass index
WC waist circumference
HOMA homeostatic model assessment
TDE tissue Doppler echocardiography
LVM left ventricular mass
MS metabolic syndrome
HOMA-IR homeostatic model assessment for insulin
resistance
LV left ventricle
FGIR fasting glucose insulin ratio
HDL high density lipoprotein
SDS standard deviation score
EM early diastolic myocardial velocity
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Obesity is currently regarded as a publichealth problem that affects both children
and adults [1]. It has been shown that obesity is
associated with the development of early myocar-
dial and coronary artery changes in children and
adolescent [2]. Therefore, prior to the onset of left
ventricular systolic dysfunction, emergence of
diastolic dysfunction in obese children might lead
to diagnosis in a very early stage of the disease [3].
Obesity affects cardiovascular parameters such as
left ventricular mass (LVM) and cardiac function
as well as metabolic parameters such as insulin
levels and glucose tolerance [4]. Tissue Doppler
echocardiography (TDE) is a recent echocardio-
graphic imaging technique that allows evaluation
of regional myocardial systolic and diastolic func-
tion [5]. Metabolic syndrome (MS) is characterized
by central obesity, insulin resistance, hyper-
glycemia, dyslipidemia, and hypertension [6].
Adipose tissue serves not only as an energy stor-
age organ, but also as an endocrine organ by
releasing factors into the circulation that have
sites of action [7]. Leptin is a peptide hormone that
is predominantly produced in adipose tissue [8].
In addition to its effect on neuroendocrine,
immune, and reproductive systems, leptin regu-
lates food intake, body weight, and energy home-
ostasis [9]. Increased adiposity was shown to be
associated with hyperleptinemia, which subse-
quently causes endothelial dysfunction, hyperten-
sion, and cardiovascular diseases [10]. Leptin is
proposed as biomarker in children for predicting
MS, Type 2 diabetes, or cardiovascular disease
[11]. This study aimed to assess the LVM index
(LVMI) and serum leptin level in obese nonhyper-
tensive children and their prediction to metabolic
syndrome.Patients and methods
A cross-sectional study that comprised 82 obese
children and 40 healthy children was conducted
in al Jeddani Hospital and Ibn Sina College
Hospital in Saudi Arabia from July 2012 to
December 2013. The obese group consisted of 82
children (47 boys and 35 girls) aged 6–14 years.
Their mean ± standard deviation age was
10.2 ± 2.8 years and mean body mass index (BMI)
32.8 ± 4.6 kg/m2. The obese children had BMI
P95th percentile for age and sex based on the
standards of the Centers for Disease Control and
Prevention.The control group consisted of 40 children (22
boys and 18 girls) aged 6–14 years. Their mean
age was 10.6 ± 2.7 years and their mean BMI was
18.7 ± 2.9 kg/m2. The control participants were
recruited from a population of nonobese healthy
children who presented to the hospital for minor
illnesses. The obese patients were divided into
the MS group (n = 25) and non-MS group (n = 57)
according to the International Diabetes Federation
consensus definition of MS in children and
adolescents [12]. A local ethical committee
was approved from our hospital (al Jeddani
Hospital). Informed consent was obtained from
parents of patients and controls. Children were
excluded if they had: previous cardiac disease or
taken medication known to affect cardiac function
(antihypertensive drugs); an earlier major illness,
including type 1 diabetes; taken medications;
had a condition that is known to influence their
growth, insulin action, or insulin secretion (e.g.,
glucocorticoid therapy, hypothyroidism, and
Cushing’s disease); or liver disease or impaired
liver functions (see Figs. 1 and 2).
Anthropometric measures
For each child, the height and weight were mea-
sured. The height was measured to the nearest
0.1 cm using a Holtain portable anthropometer
(manufacturer, address), and the weight was
determined to the nearest 0.01 kg using a Seca
scale balance (manufacturer, address) with the
patient dressed in minimal clothes and without
shoes. The BMI was calculated as weight (in kg)
divided by height (in m) squared. Waist circum-
ference (WC) was measured at the level of the
umbilicus with the child standing and breathing
normally. Each measurement was taken as the
mean of three consecutive measurements, using
standardized equipment and following the
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Figure 1. Doppler echocardiography showing reversed E/A ratio of
the mitral valve flow.
Figure 2. Tissue Doppler echocardiography on the lateral mitral
annulus showing normal early diastolic myocardial velocity.
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LVMI AND METABOLIC SYNDROME IN OBESE CHILDRENrecommendations of the International Biological
Program.
Biochemical measurements
Fasting venous blood samples were collected in
plain tubes using a standard venipuncture asep-
tic technique. The samples were allowed to clot
and sera were separated by centrifugation and
stored in aliquots at 80 C until assayed. Fasting
glucose was measured using a quantitative enzy-
matic colorimetric commercial kit provided by
Stanbio according to the glucose oxidase method
[14]. The human leptin assay utilized 125I-labeled
human leptin and human leptin antiserum to
determine leptin levels [15]. The detection limit
of the assay was 0.5 ng/mL. Plasma concentra-tions of total cholesterol, high-density lipopro-
tein, low-density lipoprotein, and triglycerides
were measured using routine enzymatic methods
with Olympus 2700 Analyzer (Tokyo, Japan).
Insulin levels were measured using a chemilumi-
nescence immunoassay. The homeostatic model
assessment for insulin resistance (HOMA-IR)
index was calculated according to the following
equation HOMA-IR = fasting insulin concentra-
tion (lU/mL)  fasting glucose concentration
(mM)/22.5 [7].
Definitions of MS
Based on the MS criteria proposed by the Inter-
national Diabetes Federation [12], patients were
diagnosed as having MS when their WC was
P90th percentile and when at least two of the fol-
lowing factors were present: (1) raised concentra-
tion of triglycerides: P150 mg/dL (1.7 mM) or
receiving specific treatment for high triglycerides;
(2) reduced concentration of high-density lipopro-
tein (HDL) cholesterol: <40 mg/dL (1.03 mM) or
receiving specific treatment for this lipid abnor-
mality; (3) raised blood pressure (BP): systolic BP
P130 mmHg or diastolic BPP85 mmHg or receiv-
ing treatment for previously diagnosed hyperten-
sion; and (4) raised fasting plasma glucose
concentration 100 mg/dL (5.6 mM) or known type
2 diabetes mellitus.
Echocardiographic measurements
All studies were performed using SCD-Alpha 7
Aloka Color Doppler Ultrasound Machine with
UST-9120 (Manufacturer, address) equipped with
tissue Doppler imaging technology. All patients
underwent a complete two-dimensional, M mode,
color Doppler imaging and TDE. During standard
echocardiographic studies, diameters of left
atrium, dimensions of left ventricle (LV), thickness
of interventricular septum and posterior wall, LV
fractional shortening, and ejection fraction were
determined using parasternal long-axis approach.
Ejection fraction is the fraction of the end-diastolic
volume that is ejected with each beat; that is, it is
stroke volume (SV) divided by end-diastolic vol-
ume (EDV) [16]:
Ef% ¼ SVEDV 100
Under the guidance of two-dimensional and
M-mode echocardiography, via parasternal long-axis
view, left atrial systolic diameter, LV end-systolic
diameter, LV end-diastolic diameter, LV posterior
wall, and interventricular septum thickness were
measured. The LVM was calculated using the for-
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equation: LVM = 0.8 [1.04  (interventricular septal
thickness + posterior wall thickness + end-diastolic
diameter)3 (end-diastolic diameter)3] + 0.6. The
LVMI was calculated as LVM divided by the body
surface area and measured by g/m2 [by the formula
LVMI = LVM/height (m)2.7].
LV diastolic functions were evaluated using
Doppler echocardiography and TDE. With apical
four-chamber view, the sample volume was
placed on mitral valve cusps (LV inflow region),
and direction of the Doppler waves were adjusted
so as to parallel blood flow. Then peak early (E)
and late (A) transmitral filling velocities and E/A
ratio were measured. By using TDE, the LV dias-
tolic function was evaluated by the early (Em)
diastolic myocardial velocities by recording the
mitral Doppler signals in the apical four-
chamber view, with the sample volume placed at
the lateral walls of mitral annulus.Statistical analysis
SPSS version 9 (SPSS, Chicago, IL, USA) was
used for data analysis. All data were expressed
as mean ± standard deviation. The Student t test
for quantitative independent variables was used
for analysis of difference between two groups.
Pearson’s correlation test was used. Analysis of
two independent variables was done using a non-
parametric test (Mann–Whitney test). In all tests,
p < 0.05 was considered significant.Table 1. Clinical and laboratory characteristics of the studied child
Obese children n = 8
Age (y) 10.2 ± 2.8
Male/female 47/35
BMI (kg/m2) 32.8 ± 4.6
BMI-SDS 2.8 ± 0.6
Duration of obesity 3.8 ± 3.2
Heart rate (beats/min) 90 ± 14
Systolic BP (mmHg) 112 ± 16
Diastolic BP (mmHg) 78 ± 12
Waist circumference (cm) 88.4 ± 13.8
Total cholesterol (mg/dL) 168.9 ± 44.4
Triglycerides (mg/dL) 118.6 ± 48.9
LDL cholesterol (mg/dL) 128.9 ± 33.2
HDL cholesterol (mg/dL) 40.1 ± 9.8
Fasting glucose (mg/dL) 89.4 ± 15
Fasting insulin (lU/mL) 18.2 ± 10.2
FGIR 4.7 ± 1.3
HOMA-IR 4.06 ± 2.2
Serum leptin level (ng/mL) 20.2 ± 6.2
Boys 17.9 ± 6.6
Girls 24.1 ± 1.9
BMI = body mass index; BP = blood pressure; FGIR = fasting glucose insulin
assessment for insulin resistance; SDS = standard deviation score.Results
The baseline and laboratory characteristics of 82
obese children and 40 control group are reported
in Table 1. BMI, BMI standard deviation score
(SDS), heart rate, fasting blood glucose, fasting
serum insulin levels, HOMA-IR, total cholesterol,
triglycerides, low-density lipoprotein (LDL),
serum leptin level, and waist circumference were
significantly higher in obese children compared
with the control group. Obese children had signif-
icantly lower HDL level compared with the control
group. The systolic BP and diastolic BP showed no
significant difference between both groups. Also,
the serum leptin level in obese girls was signifi-
cantly higher than in obese boys.
Table 2 shows that the LVMI of obese children
was significantly higher compared with the con-
trol group (p < 0.001), while ejection fraction and
fractional shortening of the left ventricle did not
differ significantly in obese versus control group
(p > 0.05). The diastolic function of the left ventri-
cle in obese children (mitral E wave, A wave,
E/A ratio, and Em signal) showed no significant
statistical difference when compared with the con-
trol group. Doppler echocardiography and TDE
measurements did not differ significantly between
the two groups (p = 0.35).
Table 3 shows the clinical and laboratory results,
and LVMI in obese children with MS (n = 25) and
without MS (n = 57). MS children had significantly
higher LVMI, serum leptin, fasting serum insulin,ren.
2 Control group n = 40 p
10.6 ± 2.7 0.45
22/18 0.8
18.7 ± 2.9 <0.001
2.1 ± 1.1 <0.001
— —
75 ± 13 0.001
110 ± 15 0.05
74 ± 8 0.058
56.2 ± 12.8 0.001
142.6 ± 38.8 0.001
80.9 ± 34.8 0.001
81.2 ± 26.4 0.001
50.9 ± 8.8 0.001
81.6 ± 12 0.004
8.6 ± 3.8 <0.001
8.9 ± 3.6 <0.001
1.8 ± 0.8 <0.001
5.2 ± 2.4 <0.001
4.4 ± 3.8 <0.001
6.9 ± 2.8 <0.001
ratio; HDL = high density lipoprotein; HOMA-IR = homeostatic model
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Table 2. Comparisons of echocardiographic data between obese and control group.
Characteristic Obese Non-obese p
Ejection fraction (%) 65.96 ± 6.28 67.44 ± 5.94 0.21
Fractional shortening (%) 35.2 ± 4.8 36.66 ± 4.34 0.1
Mitral E wave (m/s) 0.92 ± 0.18 0.91 ± 0.14 0.75
Mitral A wave (m/s) 0.57 ± 0.14 0.58 ± 0.18 0.73
Mitral E/A 1.60 ± 0.28 1.57 ± 0.29 0.88
Em (cm/s) 18.9 ± 5.2 19.8 ± 4.8 0.35
LVMI (g/m2.7) 56.6 ± 14.1 42.7 ± 12.6 <0.001
Em = early diastolic myocardial velocity; LVMI = left ventricular mass index.
Table 3. Clinical and laboratory data, and left ventricular mass index (LVMI) in obese children with and without metabolic
syndrome (MS).
MS group n = 25 Non-MS group n = 57 p
BMI (kg/m2) 32.8 ± 4.4 31.2 ± 4.6 0.14
BMI-SDS 2.7 ± 0.6 2.6 ± 0.5 0.43
Systolic BP (mmHg) 116 ± 12 107 ± 14 0.006
Diastolic BP (mmHg) 78 ± 10 75 ± 12 0.27
Waist circumference (cm) 86.8 ± 13.6 84.6 ± 13.9 0.5
Triglycerides (mg/dL) 138.6 ± 35.8 102.9 ± 32.2 0.001
HDL cholesterol (mg/dL) 41.8 ± 8.8 44.8 ± 12.8 0.29
LDL cholesterol (mg/dL) 107.6 ± 35.4 104.6 ± 32.4 0.7
Fasting glucose (mg/dL) 88.6 ± 14 86.6 ± 13 0.53
Fasting insulin (lU/mL) 25.2 ± 11.8 15.8 ± 8.8 <0.001
FGIR 3.4 ± 1.1 5.7 ± 1.4 <0.01
HOMA-IR 5.4 ± 3.8 3.5 ± 2.4 <0.01
LVMI (g/m2) 60.8 ± 17.4 50.6 ± 17.6 0.017
Serum leptin level (ng/mL) 21.8 ± 7.9 16.5 ± 7.0 <0.01
Boys 18.9 ± 4.8 15.3 ± 5.8 <0.01
Girls 24.8 ± 1.9 18.9 ± 6.8 <0.01
BP = blood pressure; BMI = body mass index; FGIR = fasting glucose insulin ratio; HDL = high density lipoprotein; HOMA-IR = homeostatic model
assessment for insulin resistance; LVMI = left ventricular mass index; SDS = standard deviation score.
Table 4. Correlation between serum leptin and various parameters in obese children with and without metabolic syndrome (MS).
Leptin in obese children with MS Leptin in obese children without MS
r p r p
BMI 0.724 <0.001 0.625 <0.001
Systolic BP 0.128 0.06 0.168 0.07
Diastolic BP 0.154 0.07 0.178 0.08
Waist circumference 0.822 <0.001 0.804 <0.001
Total cholesterol 0.188 0.08 0.190 0.08
Triglycerides 0.084 0.422 0.094 0.482
LDL cholesterol 0.166 0.123 0.202 0.148
HDL cholesterol 0.026 0.812 0.036 0.654
Fasting glucose 0.482 <0.01 0.422 <0.01
Fasting insulin 0.435 0.01 0.388 0.01
HOMA-IR 0.328 0.01 0.358 0.01
LVMI 0.345 <0.01 0.335 <0.01
BP = blood pressure; BMI = body mass index; FGIR = fasting glucose insulin ratio; HDL = high density lipoprotein; HOMA-IR = homeostatic model
assessment for insulin resistance.
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children, while no significant difference between
the MS and non-MS children regarding BMI,
BMI-SDS, WC, fasting blood glucose, total choles-
terol, LDL, and HDL levels was found (p > 0.05).Table 4 shows that, in both MS and non-MS
groups, the serum leptin had a positive correlation
with BMI, WC, triglycerides, fasting glucose, fast-
ing insulin, HOMA-IR, and LVMI, but showed a
negative correlation with HDL. There was no cor-
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Table 5. Correlations between left ventricular mass index (LVMI) and cardiovascular risk factors in obese children with and without
metabolic syndrome (MS).
LVMI in obese children with MS LVMI in obese children without MS
r p r p
BMI 0.344 0.005 0.196 0.008
BMI-SDS 0.358 <0.005 0.560 0.001
Systolic BP 0.330 0.017 0.248 0.021
Diastolic BP 0.242 0.012 0.216 0.024
Waist circumference 0.220 0.015 0.260 0.004
Triglycerides 0.394 0.001 0.312 <0.01
HDL cholesterol 0.047 0.350 0.060 0.11
Fasting insulin 0.322 0.009 0.359 <0.001
FGIR 0.355 0.014 0.312 <0.001
HOMA-IR 0.324 0.011 0.343 <0.001
BP = blood pressure; BMI = body mass index; FGIR = fasting glucose insulin ratio; HDL = high density lipoprotein; HOMA-IR = homeostatic model
assessment for insulin resistance; SDS = standard deviation score.
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group with blood pressure, total cholesterol, or
LDL.
Table 5 shows the correlations between LVMI
and other measurements in obese children and
those of MS. When LVMI was considered as a
continuous variable in the whole population of
obese children, it was found positively correlated
with BMI-SDS, WC, systolic BP, diastolic BP,
triglycerides, fasting insulin levels, HOMA-IR
and fasting glucose insulin ratio, and negatively
correlated with HDL cholesterol.
In receiver operating characteristic analysis, the
results showed that an LVMI value of >38 g/m2
was the best cut-off value in predicting metabolic
syndrome in obese children with a sensitivity of
95% and a specificity of 84% (Fig. 3).Discussion
Obesity is an important risk factor for
atherosclerotic cardiovascular disease. Risk factorFigure 3. Receiver operating characteristic curve of left ventricular
mass index cut-off value in predicting metabolic syndrome.control in young people might retard the progres-
sion of atherosclerosis [2]. Therefore, it is very
important to study the structural and functional
cardiac changes and assess the serum leptin level
in obese children and study their relations to
parameters of MS in children.
In this study, the obese group showed signifi-
cant increase in the mean level of triglycerides,
total cholesterol, LDL, fasting glucose level, fast-
ing insulin level, and HOMA-IR when compared
to the control group. However, the level of HDL
showed a significant decrease in obese children
when compared to control group. This can be
explained and supported by studies that found
that both obesity and type 2 diabetes are associ-
ated with dyslipidemia and insulin resistance
[18], although most obese, insulin-resistant indi-
viduals do not develop hyperglycemia unless
there is impaired B cell function [19].
In our study, assessment of systolic function by
measuring ejection fraction and fractional short-
ening showed normal results with no significant
statistical difference between obese children and
control group, and even between MS obese chil-
dren and non-MS obese children. Similarly, most
echocardiographic studies that assessed systolic
function in obese individuals showed normal
results [20,21]. Chinali et al. [22] and Pascual
et al. [23] reported that a reduction of indices of
systolic function was only found in patients with
a considerable degree of obesity, suggesting that
left ventricular function is affected late in the
course of obesity.
The diastolic functions in our obese children
(through echo Doppler and TDE) showed no sig-
nificant statistical difference when compared to
control group. Some studies have specifically
investigated the impact of obesity on diastolic
function in children found normal results by using
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LVMI AND METABOLIC SYNDROME IN OBESE CHILDRENecho Doppler [24–27]. In contrast to most results,
Harada et al. [28] found altered transmitral and
pulmonary venous velocities in 21 obese children
using pulse wave Doppler, suggesting a reduction
in early diastolic filling. Mehta et al. used TDE to
measure the diastolic function in obese children,
and revealed impaired diastolic function [29].
Other studies using TDE to assess the effects of
childhood obesity on diastolic function have
reported similar findings [24,25,30,31].
In this study, the LVMI in obese children was
significantly higher when compared to control
group and also more significant in MS obese chil-
dren when compared to non-MS obese children.
Moreover, a significantly positive correlation was
detected between LVMI and parameters of MS
syndrome and also with those of insulin resistance
this suggests that MS may have a harmful effect
on myocardial structure [32]. Some studies found
a relationship between insulin resistance and
LVM whereas others found no relationship at all
[18,22,33–36]. The association of MS with cardiac
hypertrophy might be explained also by non-
hemodynamic factors, such as insulin resistance
and the accompanying compensatory hyperinsu-
linemia, which are considered to be the major
pathophysiological features underlying the MS
[37].
This study demonstrates that leptin levels were
significantly higher in obese children when com-
pared with the control group. This finding was
confirmed by other studies [38,39]. Our study con-
firms previous findings of higher leptin levels in
obese girls [40,41]. This is attributed to inhibitory
effect of testosterone on leptin production [42].
Despite good correlation of leptin and BMI, we
observed significant variability in leptin levels in
individuals with similar BMI. This may be related
to differences in body composition and fat distri-
bution. Maffie et al. described significant hetero-
geneity in leptin concentration in individuals
with similar BMI [43]. In our study, a positive cor-
relation was seen between serum leptin with the
triglycerides, fasting insulin, fasting glucose, and
HOMA-IR and negative correlation was seen with
HDL. These observations indicate a role of leptin
resistance in the pathogenesis of dyslipidaemia.
Leptin levels are shown to predict the develop-
ment of MS independent of baseline obesity [44].
Some studies found no significant relationship
between leptin and lipids [38,45], whereas another
study found that lipids showed significant correla-
tion with leptin levels [46].
Lastly, in this study, the serum leptin was posi-
tively correlated with LVMI. This confirms otherstudies that showed same results in adolescence
and young adults [47,48], although some studies
showed no correlation between leptin and LVM
[49], or that even higher leptin level was associ-
ated with lower LVM [50].Conclusion
The main findings in the current study are: (1)
serum leptin was significantly higher in obese
children with MS; (2) obese children with MS
had insulin resistance; (3) LVMI was significantly
correlated with both serum leptin level and insu-
lin resistance in obese children with MS; and (4)
a value of P38 g/m2 LVMI was the optimal cut-
off in predicting MS in obese children. We suggest
that assessment of LVMI as a routine echocardio-
graphic examination of obese children might be
used in predicting the presence of MS and insulin
resistance.
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